Angela Williams‐Diaz

3.1k total citations · 1 hit paper
13 papers, 944 citations indexed

About

Angela Williams‐Diaz is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Angela Williams‐Diaz has authored 13 papers receiving a total of 944 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 7 papers in Epidemiology and 2 papers in Virology. Recurrent topics in Angela Williams‐Diaz's work include SARS-CoV-2 and COVID-19 Research (5 papers), Respiratory viral infections research (4 papers) and COVID-19 Clinical Research Studies (4 papers). Angela Williams‐Diaz is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), Respiratory viral infections research (4 papers) and COVID-19 Clinical Research Studies (4 papers). Angela Williams‐Diaz collaborates with scholars based in United States, Russia and France. Angela Williams‐Diaz's co-authors include Xia Xu, Daniel S Berger, Peter Sklar, Richard B. Pollard, José Valdez Madruga, Bach-Yen Nguyen, Edwin DeJesus, Richard J. O. Barnard, Michael D. Miller and Jeffrey L. Lennox and has published in prestigious journals such as The Lancet, Annals of Internal Medicine and Clinical Infectious Diseases.

In The Last Decade

Angela Williams‐Diaz

11 papers receiving 910 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

2009 478 citations Jeffrey L. Lennox, Edwin DeJesus et al. The Lancet profile →

Peers

Countries citing papers authored by Angela Williams‐Diaz

Since Specialization

Citations

This map shows the geographic impact of Angela Williams‐Diaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Williams‐Diaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Williams‐Diaz more than expected).

Fields of papers citing papers by Angela Williams‐Diaz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela Williams‐Diaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Williams‐Diaz. The network helps show where Angela Williams‐Diaz may publish in the future.

Co-authorship network of co-authors of Angela Williams‐Diaz

This figure shows the co-authorship network connecting the top 25 collaborators of Angela Williams‐Diaz. A scholar is included among the top collaborators of Angela Williams‐Diaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela Williams‐Diaz. Angela Williams‐Diaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Impact of differences between interim and post-interim analysis populations on outcomes of a group sequential trial: Example of the MOVe-OUT study 2025 ·Clinical Trials ·Yoseph Caraco, Matthew G. Johnson, (unknown), Brian M. Maas, Julie A. Stone, Matthew L. Rizk, (unknown), Julie Strizki, Angela Williams‐Diaz, Michelle Brown, (unknown), Hong Wan, Alison Pedley, Akshita Chawla, (unknown), Jay A. Grobler, Amanda Paschke, Carisa De Anda	0
2	Respiratory virus coinfections during the COVID-19 pandemic: epidemiologic analysis and clinical outcomes from the Phase 2/3 molnupiravir trial (MOVe-OUT) 2024 ·Microbiology Spectrum ·Matthew G. Johnson, Julie Strizki, Erin Jensen, Jonathan Cohen, Christine Katlama, Roman Fishchuk, Alfredo Ponce‐de‐León, (unknown), Chien‐Yu Cheng, Dorothy McCoy, (unknown), (unknown), Ying Zhang, Angela Williams‐Diaz, Michelle Brown, (unknown), Jay A. Grobler, Amanda Paschke, Carisa De Anda	0
3	Impact of Molnupiravir Treatment on Patient-Reported COVID-19 Symptoms in the Phase 3 MOVe-OUT Trial: A Randomized, Placebo-Controlled Trial 2023 ·Clinical Infectious Diseases ·(unknown), Amy Puenpatom, Matthew G. Johnson, Ying Zhang, Yujie Zhao, Joseph Surber, Aaron Weinberg, Carlos Brotons, Roman S. Kozlov, (unknown), Kathleen Coetzee, (unknown), Jiejun Du, Angela Williams‐Diaz, Michelle Brown, Amanda Paschke, Carisa De Anda, Josephine M. Norquist	9
4	Molnupiravir for the treatment of COVID-19 in immunocompromised participants: efficacy, safety, and virology results from the phase 3 randomized, placebo-controlled MOVe-OUT trial 2023 ·Infection ·Matthew G. Johnson, Julie Strizki, Michelle Brown, Hong Wan, Hala Shamsuddin, Moti Ramgopal, Diana F. Florescu, Pierre Delobel, И. М. Хаертынова, (unknown), (unknown), Shan‐Chwen Chang, Angela Williams‐Diaz, Jiejun Du, Jay A. Grobler, Amanda Paschke, Carisa De Anda	23
5	Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19 2022 ·Annals of Internal Medicine ·Matthew G. Johnson, Amy Puenpatom, Pablo Andrés Moncada, Lesley Burgess, Elizabeth R. Duke, Norio Ohmagari, Timo Wolf, Matteo Bassetti, Sanjay Bhagani, Jade Ghosn, Ying Zhang, Hong Wan, Angela Williams‐Diaz, Michelle Brown, Amanda Paschke, Carisa De Anda	44
6	Phase 2/3 Trial of Molnupiravir for Treatment of Covid-19 in Nonhospitalized Adults 2021 ·NEJM Evidence ·Yoseph Caraco, Gordon Crofoot, Pablo Andrés Moncada, A.N. Galustyan, (unknown), Brendan Payne, (unknown), Antonio Herrero, Michelle Brown, Angela Williams‐Diaz, Wei Gao, Julie Strizki, Jay A. Grobler, Jiejun Du, Christopher Assaid, Amanda Paschke, Joan R. Butterton, Matthew G. Johnson, Carisa De Anda	68
7	Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults 2019 ·Human Vaccines & Immunotherapeutics ·(unknown), Jeffrey B. Rosen, James T. Peterson, Angela Williams‐Diaz, (unknown), Tina M. Sterling, Camilo J. Acosta, Katrina M. Nolan, Jianing Li, Alison Pedley, (unknown), Chitrananda Abeygunawardana, (unknown), William J. Smith, Hari Pujar, Luwy Musey	83
8	Cellular and Humoral Responses to a Second Dose of Herpes Zoster Vaccine Administered 10 Years After the First Dose Among Older Adults 2015 ·The Journal of Infectious Diseases ·Myron J. Levin, Kenneth E. Schmader, Lei Pang, Angela Williams‐Diaz, Gary O. Zerbe, Jennifer Canniff, Michael Johnson, Yupanqui Caldas, Alice Cho, Nancy Lang, Shu‐Chih Su, Janie Parrino, Zoran Popmihajlov, Adriana Weinberg	54
9	Long‐Term Tolerability of Telcagepant for Acute Treatment of Migraine in a Randomized Trial 2010 ·Headache The Journal of Head and Face Pain ·Kathryn M. Connor, Sheena K. Aurora, Tom Loeys, Messoud Ashina, Christopher J. Jones, Hilde Giezek, Rachid Massaad, Angela Williams‐Diaz, Christopher Lines, Tony W. Ho	70
10	Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial breakdown → 2009 ·The Lancet ·Jeffrey L. Lennox, Edwin DeJesus, Adriano Lazzarin, Richard B. Pollard, José Valdez Madruga, Daniel S Berger, Jing Zhao, Xia Xu, Angela Williams‐Diaz, Anthony Rodgers, Richard J. O. Barnard, Michael D. Miller, Mark J. DiNubile, Bach-Yen Nguyen, Randi Y. Leavitt, Peter Sklar	478
11	Efficacy and Safety of Caspofungin in Solid Organ Transplant Recipients 2007 ·Transplantation Proceedings ·Jelena Petrović, A. Ngai, Susan K. Bradshaw, Angela Williams‐Diaz, Amanda Taylor, Carole A. Sable, Scott Vuocolo, Nicholas A. Kartsonis	15
12	Caspofungin for the treatment of less common forms of invasive candidiasis 2007 ·Journal of Antimicrobial Chemotherapy ·Oliver A. Cornely, Martín Lasso, Robert F. Betts, Н Н Климко, José A. Vázquez, Geoff Dobb, Juan D. Vélez, Angela Williams‐Diaz, Joy Lipka, Arlene Taylor, Carole A. Sable, Nicholas A. Kartsonis	99
13	P978 Efficacy and safety of caspofungin in solid organ transplant recipients 2007 ·International Journal of Antimicrobial Agents ·Jelena Petrović, A. Ngai, Susan K. Bradshaw, Angela Williams‐Diaz, Amanda Taylor, Carole A. Sable, Nicholas A. Kartsonis	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact